FindTrial
Sign In

Study on Modified Tingli Dazao Xiefei Decoction in the Treatment of Severe Pneumonia with phlegm-damp type

Study on Modified Tingli Dazao Xiefei Decoction in the Treatment of Severe Pneumonia with phlegm-damp type

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076467
Enrollment
Unknown
Registered
2023-10-09
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Pneumonia with Phlegm and Salivary Obstruction

Interventions

treatment group:Modified Tingli Dazao Xiefei Decoction
control group:hot water

Sponsors

Guangzhou Red Cross Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: ( 1 ) Fulfilled the diagnostic criteria of severe pneumonia with phlegm-damp type in traditional Chinese medicine; ( 2 ) Meet the diagnostic criteria of severe pneumonia in Western medicine ; ( 3 ) APACHEII score = 10 points, and = 30 points ; ( 4 ) Age between 18-85 years old.

Exclusion criteria

Exclusion criteria: ( 1 ) Family members or patients do not agree with or can not comply with treatment ; ( 2 ) TCM syndrome differentiation data incomplete : ( 3 ) Pulmonary infection caused by lung cancer and tuberculosis ; or other non-infectious pneumonia ; ( 4 ) Patients with parathyroid disease ; ( 5 ) Pregnant or lactating women ; ( 6 ) Patients who are allergic to this drug.

Design outcomes

Primary

MeasureTime frame
Total Efficiency;—

Secondary

MeasureTime frame
IL-6, CRP, PCT;—

Countries

China

Contacts

Public ContactXundong Lai

Guangzhou Red Cross Hospital

13922218863@163.com+86 139 2221 8863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026